FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 4131502 · Received October 1, 2014

Report

Report Number
2124215-2014-13755
Event Type
Injury
Date Received
October 1, 2014
Date of Event
June 27, 2014
Report Date
August 12, 2014
Manufacturer
CPI PLANT - ST. PAUL
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE PRODUCT IS EXPECTED TO BE RETURNED FOR ANALYSIS. THIS REPORT WILL BE UPDATED UPON RETURN AND COMPLETION OF ANALYSIS.

Additional Manufacturer Narrative · 1

(B)(4). THIS LEAD HAS BEEN RETURNED. BOSTON SCIENTIFIC HAS CONCLUDED IT IS UNLIKELY THAT LEAD CHARACTERISTICS CAUSED OR CONTRIBUTED TO THE REPORTED CLINICAL OBSERVATIONS. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS DEVICE DELIVERED AN INAPPROPRIATE SHOCK. DURING A FOLLOW-UP, RADIOGRAPHY CONFIRMED THAT THE RIGHT VENTRICULAR (RV) LEAD HAD DISLODGED AND WAS IN THE ATRIUM. AS A RESULT, THE LEAD WAS EXPLANTED AND REPLACED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
611382 ENDOTAK RELIANCE IMPLANTABLE LEAD LWS CPI PLANT - ST. PAUL 0695

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R 0695